Merck Fosamax Reminder Ads Should Be Withdrawn - FDA Ad Division
Executive Summary
Merck Fosamax broadcast reminder ads should be withdrawn due to their product-specific content, FDA's ad division told Merck in a July 16 letter.
You may also be interested in...
Vioxx DTC Ads Consistent With “Learned Intermediary” Defense, Merck Says
The extensive direct-to-consumer advertising for Vioxx will not undercut Merck's ability to assert a "learned intermediary" defense against personal injury claims, the company told analysts Dec. 14
Vioxx DTC Ads Consistent With “Learned Intermediary” Defense, Merck Says
The extensive direct-to-consumer advertising for Vioxx will not undercut Merck's ability to assert a "learned intermediary" defense against personal injury claims, the company told analysts Dec. 14
Vioxx Withdrawal Fuels Criticism Of DTC; Liability Exposure May Be Test
The Vioxx withdrawal will prompt renewed debate over DTC advertising